FOXP4 and ovarian carcinoma: Reduced inflammation is associated with better outcomes in ovarian cancer as demonstrated by previous studies.[30,37] Our findings suggest that FOXP4-AS1 plays an important role in the regulation of immune cell infiltration and inflammatory response in OVs.